New combo treatment for liver metastases shows early promise in pilot trial
NCT ID NCT06311851
First seen Jan 07, 2026 · Last updated May 25, 2026 · Updated 24 times
Summary
This study tests a new approach for people with liver metastases (cancer that has spread to the liver from another part of the body). Doctors will deliver the drug bevacizumab directly into the liver along with standard chemo during a procedure called TACE. The goal is to see if this combination is safe and helps patients live longer. About 40 adults whose liver cancer cannot be surgically removed will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pardis Noor Medical Imaging and Cancer Center
RECRUITINGTehran, Tehran Province, 021, Iran
Contact
Conditions
Explore the condition pages connected to this study.